About Us

We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.

Our purpose: We’re on course to transform the practice of medicine through breakthrough science, and to make a positive impact on the people and communities we serve.

For the last 33 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

30.5m

Patients reached with XonafiMed medicines

25.3m

Treatments

2.5bn

Investment in research and development (USD)

50,612

People (own operations)

OUR SERVICES

Offering a custom solution for every requirement…

At XonafiMed, we share a common goal: to put patients first and help people around the world live better and healthier lives. We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place. It was Donald E. vision at the beginning and it holds true today.

BIOTHERAPEUTICS

Create better biologic treatments and speed your path to market with our range of advanced technologies and services. Whether you are looking for standalone services or leveraging Catalent’s Follow the Molecule® approach for an integrated solution, our experts can help you take your biologic from cell line development through to finished product supply. We have the expertise, experience and advanced technologies to provide you seamless solutions and time savings to get your biologics to clinic or market quickly and reliably.

GENE THERAPY CDMO

Best-in-class expertise in bridging the gap from viral vector Process Development to CGMP manufacturing. With more than 30 years of experience in biologics services and partnerships with more than 20 premier gene therapy companies, Catalent is your trusted gene therapy CDMO partner for custom viral vector development and scalable manufacturing of adeno-associated virus (AAV) vectors, next-generation vaccines, and oncolytic viruses. We have experience with more than 60 gene therapy programs across various stages of development, a commercially approved manufacturing facility, and a total plasmid and gene therapy footprint of 600,000+ square feet. Let our Gene Therapy experts create a custom, scalable solution for your next groundbreaking therapeutic.

CELL THERAPY CDMO

Advancing technologies and capabilities in cell therapy development and manufacturing. XonafiMed’s broad and industry-leading cell therapy expertise enables access to comprehensive solutions to get your life-saving cell therapies to the clinic faster and commercialize them more efficiently. With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, XonafiMed is your full-service CDMO partner for cell therapy. Our unique and comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including chimeric antigen receptor T cells (CAR-T), T cell receptors (TCR), tumor-infiltrating leukocytes (TILs), natural killer cells (NKs), iPSCs, and MSCs. XonafiMed enables fully integrated cell therapy services, from iPSC differentiation, development, and manufacturing expertise, to process and analytical development across cell types, to clinical and commercial manufacturing in the United States and Europe.

OUR WORK

Research & Development

We’re driven by the XonafiMed purpose: To deliver innovative medicines that alleviate society’s greatest disease burdens. As a focused R&D engine, we’re designed to turn breakthrough science into transformative, high-value treatments that have the most potential to improve and extend the lives of patients.